Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „canagliflozin“
Suchtreffer
Begriffe & Kennungen
Vokanamet · 4.5 · 10 In interaction studies, canagliflozin at steady-state had no clinically relevant effect on the pharmacokine
Eintrag öffnenVokanamet · 4.5 · Canagliflozin
Eintrag öffnenVokanamet · 4.5 · Canagliflozin is not recommended for use in patients receiving loop diuretics.
Eintrag öffnenVokanamet · 4.5 · Canagliflozin may add to the effect of diuretics and may increase the risk of dehydration and hypotension (see
Eintrag öffnenVokanamet · 4.5 · Cholestyramine may potentially reduce canagliflozin exposure. Dosing of canagliflozin should occur at least 1
Eintrag öffnenVokanamet · 4.5 · Dabigatran The effect of concomitant administration of canagliflozin (a weak P-gp inhibitor) on dabigatran ete
Eintrag öffnenVokanamet · 4.5 · Digoxin The combination of canagliflozin 300 mg once daily for 7 days with a single dose of digoxin 0.5 mg fol
Eintrag öffnenVokanamet · 4.5 · Effects of canagliflozin on other medicinal products
Eintrag öffnenVokanamet · 4.5 · Effects of other medicinal products on canagliflozin
Eintrag öffnenVokanamet · 4.5 · If a combined inducer of these UGT enzymes and transport proteins must be co-administered with canagliflozin,
Eintrag öffnenVokanamet · 4.5 · Increases in urinary glucose excretion with canagliflozin can falsely lower 1,5-anhydroglucitol (1,5-AG) level
Eintrag öffnenVokanamet · 4.5 · Inhibition of BCRP by canagliflozin cannot be excluded at an intestinal level and increased exposure may there
Eintrag öffnenVokanamet · 4.5 · Interaction studies suggest that the pharmacokinetics of canagliflozin are not altered by metformin, hydrochlo
Eintrag öffnenVokanamet · 4.5 · Simvastatin The combination of canagliflozin 300 mg once daily for 6 days with a single dose of simvastatin (C
Eintrag öffnenVokanamet · 4.5 · The metabolism of canagliflozin is primarily via glucuronide conjugation mediated by UDP glucuronosyl transfer
Eintrag öffnenVokanamet · 4.8 · 14 There was no difference in risk of lower limb amputations associated with the use of canagliflozin 100 mg r
Eintrag öffnenVokanamet · 4.8 · Canagliflozin
Eintrag öffnenVokanamet · 4.8 · In clinical studies, urinary tract infections were more frequently reported for canagliflozin 100 mg and 300 m
Eintrag öffnenVokanamet · 4.8 · Patients treated with canagliflozin regardless of baseline eGFR experienced an initial fall in mean eGFR. Ther
Eintrag öffnenVokanamet · 4.8 · Table 3: Integrated analysis of amputations in CANVAS and CANVAS-R Placebo canagliflozin N = 4,344 N = 5,790 T
Eintrag öffnen